ArticleContemporary clinical trials2025

Randomized, placebo-controlled trial of injectable extended-release naltrexone and injectable extended-release buprenorphine for cocaine use disorder (CURB-2): Study rationale and design.

Madhukar H Trivedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.